Capstone Investment Advisors
GILD icon

Capstone Investment Advisors’s Gilead Sciences GILD Stock Holding History

Capstone Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.6M Buy
133,700
+53,900
+68% +$7.55M 0.03% 186
2025
Q4 		$9.79M Sell
79,800
-90,500
-53% -$11M 0.02% 266
2025
Q3 		$18.9M Sell
170,300
-27,700
-14% -$3.15M 0.04% 213
2025
Q2 		$22M Sell
198,000
-8,500
-4% -$905K 0.05% 133
2025
Q1 		$23.1M Sell
206,500
-160,800
-44% -$16.6M 0.06% 154
2024
Q4 		$33.9M Buy
367,300
+144,200
+65% +$13M 0.08% 143
2024
Q3 		$18.7M Sell
223,100
-14,200
-6% -$1.08M 0.06% 191
2024
Q2 		$16.3M Buy
237,300
+109,500
+86% +$7.31M 0.05% 221
2024
Q1 		$9.36M Sell
127,800
-73,800
-37% -$5.67M 0.03% 292
2023
Q4 		$16.3M Buy
201,600
+78,000
+63% +$6.07M 0.05% 247
2023
Q3 		$9.26M Buy
123,600
+30,500
+33% +$2.35M 0.04% 293
2023
Q2 		$7.18M Buy
93,100
+32,700
+54% +$2.61M 0.04% 301
2023
Q1 		$5.01M Sell
60,400
-200,400
-77% -$16.6M 0.03% 361
2022
Q4 		$22.4M Buy
260,800
+6,200
+2% +$491K 0.16% 92
2022
Q3 		$15.7M Buy
254,600
+11,100
+5% +$700K 0.09% 141
2022
Q2 		$15.1M Sell
243,500
-333,800
-58% -$20.7M 0.07% 176
2022
Q1 		$34.3M Sell
577,300
-691,300
-54% -$44.2M 0.09% 163
2021
Q4 		$92.1M Sell
1,268,600
-47,800
-4% -$3.29M 0.15% 114
2021
Q3 		$92M Buy
1,316,400
+183,400
+16% +$12.9M 0.18% 107
2021
Q2 		$78M Buy
1,133,000
+258,500
+30% +$17.3M 0.18% 114
2021
Q1 		$56.5M Buy
874,500
+325,700
+59% +$21M 0.17% 123
2020
Q4 		$32M Sell
548,800
-111,300
-17% -$6.72M 0.11% 156
2020
Q3 		$41.7M Buy
660,100
+145,000
+28% +$10.1M 0.21% 84
2020
Q2 		$39.6M Buy
515,100
+402,700
+358% +$30.9M 0.26% 65
2020
Q1 		$8.4M Sell
112,400
-348,600
-76% -$24.1M 0.14% 158
2019
Q4 		$30M Buy
461,000
+105,500
+30% +$6.87M 0.16% 138
2019
Q3 		$22.5M Buy
355,500
+63,800
+22% +$4.17M 0.15% 131
2019
Q2 		$19.7M Buy
291,700
+79,200
+37% +$5.21M 0.14% 158
2019
Q1 		$13.8M Buy
212,500
+71,800
+51% +$4.77M 0.13% 167
2018
Q4 		$8.8M Buy
140,700
+36,400
+35% +$2.54M 0.11% 151
2018
Q3 		$8.05M Buy
104,300
+51,700
+98% +$3.9M 0.09% 174
2018
Q2 		$3.73M Buy
52,600
+49,100
+1,403% +$3.47M 0.06% 190
2018
Q1 		$264K Buy
3,500
+1,400
+67% +$111K 0.01% 290
2017
Q4 		$150K Hold
2,100
– – ﹤0.01% 451
2017
Q3 		$170K Hold
2,100
– – 0.01% 492
2017
Q2 		$148K Sell
2,100
-17,300
-89% -$1.15M ﹤0.01% 582
2017
Q1 		$1.32M Sell
19,400
-9,600
-33% -$675K 0.03% 367
2016
Q4 		$2.08M Buy
+29,000
New +$2.16M 0.06% 273
2015
Q4 		– Sell
-30,000
Closed -$2.94M – 494
2015
Q3 		$2.94M Buy
+30,000
New +$3.33M 0.07% 169
2014
Q3 		– Sell
-93,700
Closed -$7.77M – 463
2014
Q2 		$7.77M Buy
+93,700
New +$7.29M 0.1% 151

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capstone Investment Advisors's GILD Position: Q1 2026 in Review

Capstone Investment Advisors opened a new position in Gilead Sciences (GILD) in Q1 2026: 6,254 shares worth $872K. The stake represents ﹤0.01% of the portfolio and ranks #906 among its holdings. This is a return to the name: Capstone Investment Advisors previously reported a position in GILD as recently as Q3 2025.

Capstone Investment Advisors first reported a position in GILD in Q1 2014 and has held it in 36 quarters since. The position peaked at $13.9M in Q1 2022. 2,312 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Capstone Investment Advisors held 6,254 shares of Gilead Sciences worth $872K as of Q1 2026.
  • Gilead Sciences was a new Capstone Investment Advisors position in Q1 2026.
  • Gilead Sciences made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #906 holding.
  • Capstone Investment Advisors first reported a position in Gilead Sciences in Q1 2014 and has held it in 36 quarters since.
  • Capstone Investment Advisors's Gilead Sciences position peaked at $13.9M in Q1 2022.
  • 2,312 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.